SCHEMBL22288293

SCHEMBL22288293

Cn1ncc(Nc2ncc(I)cn2)c1C1CC1

nearest known ligand 0.45

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.45
MAP4K1 Q92918 1/20 0.38
LRRK2 Q5S007 8/20 0.36
PIM1 P11309 9/20 0.36
PIM2 Q9P1W9 5/20 0.36
PIM3 Q86V86 4/20 0.36
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22300598 0.76 MAPK1 (0.75) MAPK1MAP4K1LRRK2CYP1A2
SCHEMBL22288262 0.72 LRRK2 (0.38) LRRK2CYP1A2
SCHEMBL21863532 0.70 MGLL (0.31) MAP4K1PIM1PIM2PIM3
SCHEMBL4562072 0.68 LRRK2 (0.67) LRRK2CYP1A2
SCHEMBL22008379 0.68 PIM1 (0.44) PIM1PIM2PIM3
SCHEMBL21046862 0.65 LRRK2 (0.50) LRRK2PIM1
SCHEMBL12967352 0.64 MAP4K4 (0.40) MAP4K1
SCHEMBL21848989 0.64 MGLL (0.30)
SCHEMBL22288311 0.64 MAPK1 (0.48) MAPK1LRRK2CYP1A2
SCHEMBL13062788 0.63 MGLL (0.33) MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111484482-B Alkynyl pyrimidine or alkynyl pyridine compound, and composition and application thereof 北京赛特明强医药科技有限公司 2022-06-21 CN disclosed
WO-2020156283-A1 ALKYNYLPYRIMIDINE OR ALKYNYLPYRIDINE COMPOUND, AND COMPOSITION AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2020-08-06 WO disclosed
WO-2020156283-A1 ALKYNYLPYRIMIDINE OR ALKYNYLPYRIDINE COMPOUND, AND COMPOSITION AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2020-08-06 WO disclosed
CN-111484482-A Alkynyl pyrimidine or alkynyl pyridine compound, and composition and application thereof 北京赛特明强医药科技有限公司 2020-08-04 CN disclosed